Concepedia

Author

Janice A. Nagy

Beth Israel Deaconess Medical CenterORCID

Also Known As

J A Nagy, J NAGY, J Nagy, J. A. Nagy, J. Nagy, J.A. NAGY, J.A. Nagy, JANICE A NAGY, JANICE A. NAGY, Janice A Nagy

184

Publications

18.7K

Citations

62

H-Index

118

Concepts

All Affiliations

Beth Israel Deaconess Medical CenterHarvard UniversityBeth Israel Deaconess HospitalCenter for Vascular Biology ResearchBoston Children's Hospital
JA

About

Janice A. Nagy is an author at Beth Israel Deaconess Medical Center specializing in medicine, vascular biology, and angiogenesis.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

35

43

8.6K

2

Health Sciences

10

10

2.1K

3

Natural Sciences

4

4

358

4

Engineering

3

3

183

5

Allergy

2

2

1.5K

Janice A. Nagy

×

88

Publications

12.6K

Citations

50

H-Index

YearCitations

Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1

Aernout Luttun, Marc Tjwa, Lieve Moons,

Nature Medicine

2002

1.1K

A human leukocyte differentiation antigen family with distinct alpha-subunits and a common beta-subunit: the lymphocyte function-associated antigen (LFA-1), the C3bi complement receptor (OKM1/Mac-1), and the p150,95 molecule.

Francisco Sánchez‐Madrid, Janice A. Nagy, E. Robbins,

The Journal of Experimental Medicine

1983

877

Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules.

Harold F. Dvorak, Janice A. Nagy, J. Dvorák,

PubMed

1988

681

The functional significance, distribution, and structure of LFA-1, LFA-2, and LFA-3: cell surface antigens associated with CTL-target interactions.

Alan M. Krensky, Francisco Sánchez‐Madrid, E. Robbins,

The Journal of Immunology

1983

574

Vascular Permeability Factor/Vascular Endothelial Growth Factor Induces Lymphangiogenesis as well as Angiogenesis

Janice A. Nagy, Eliza Vasile, Dian Feng,

The Journal of Experimental Medicine

2002

549

Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.

Harold F. Dvorak, Tracy M. Sioussat, Lawrence F. Brown,

The Journal of Experimental Medicine

1991

489

Antiangiogenic Properties of Gold Nanoparticles

Priyabrata Mukherjee, Resham Bhattacharya, Ping Wang,

Clinical Cancer Research

2005

463

Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin

Thuy L. Phung, Keren Ziv, Donnette Dabydeen,

Cancer Cell

2006

435

Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor

Ånna Pettersson, Janice A. Nagy, Lawrence F. Brown,

Laboratory Investigation

2000

415

Neutrophils Emigrate from Venules by a Transendothelial Cell Pathway in Response to FMLP

Dian Feng, Janice A. Nagy, Kathryn Pyne,

The Journal of Experimental Medicine

1998

408

Page 1